Singapore markets close in 5 hours 33 minutes

Stereotaxis, Inc. (STXS)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
2.09000.0000 (0.00%)
At close: 04:00PM EDT
2.2700 +0.18 (+8.61%)
After hours: 07:05PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.0900
Open2.0900
Bid2.0500 x 1000
Ask2.2600 x 900
Day's range2.0500 - 2.1600
52-week range1.3300 - 3.2900
Volume294,774
Avg. volume337,580
Market cap171.649M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa

    ST. LOUIS, May 15, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024, scheduled to take place during Heart Rhythm Society Scientific Sessions this week in Boston, Massachusetts. Stereotaxis will present an innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-qualit

  • GlobeNewswire

    Stereotaxis Reports 2024 First Quarter Financial Results

    ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the first quarter ended March 31, 2024. “Stereotaxis is driving continued commercial, technological, and strategic progress,” said David Fischel, Chairman and CEO. “We are pleased to report revenue growth in the first quarter and an increase in system backlog with two Genesis systems orders si

  • GlobeNewswire

    Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies

    ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has entered into a definitive share purchase agreement under which Stereotaxis will acquire Access Point Technologies EP (APT), a privately-held Minnesota-based developer of innovative electrophysiology catheters. “Acquiring APT provides Stereotaxis with high-quality catheter development and manufacturing